期刊文献+

NK4基因转染对人乳腺癌细胞MDA-MB-231生物学特性的影响 被引量:1

Inhibition of NK4 transfection on biological features of breast cancer cell MDA-MB-231
下载PDF
导出
摘要 目的通过在人乳腺癌细胞MDA-MB-231中转染携带有NK4基因的慢病毒载体,研究NK4对乳腺癌细胞的生物学特性影响及其作用机制。方法将NK4重组慢病毒载体pLenti6.3-NK4-IRES-EGFP转染人乳腺癌细胞MDA-MB-231。采用逆转录聚合酶链反应(RT-PCR)及免疫印迹法(Western blot)检测转染细胞中NK4的基因和蛋白表达,检测在肝细胞生长因子(hepatocyte growth factor,HGF)存在的条件下磷酸化c-met受体(p-met)的表达。采用MTT、Transwell小室检测转染NK4基因对乳腺癌细胞的生长、侵袭的影响。结果转染NK4基因的乳腺癌细胞MDA-MB-231能够表达并分泌NK4,RT-PCR扩增出预期的453 bp片段,Western blot显示有50 kD的蛋白并且转染组与空载体组和对照组相比p-met的表达明显减弱。MTT结果显示转染NK4组细胞生长抑制率达(67±2.04)%,较其他两组抑制率高(P<0.01),Transwell结果显示转染NK4基因能够显著抑制由HGF诱导的乳腺癌细胞的侵袭(P<0.01)。结论 NK4通过竞争性抑制HGF诱导的乳腺癌细胞中c-met受体的磷酸化从而抑制了乳腺癌的生长、侵袭。 Objective To investigate the effects of NK4 transfection on biological features of breast cancer cells MDA-MB-231 by transfecting pLenti6.3-NK4-IRES-EGFP into cells.Methods The pLenti6.3-NK4-IRES-EGFP was trasfected into MDA-MB-231 cells.Expression of NK4 gene and protein was identified by RT-PCR and Western blot respectively.Phospho-met(P-met) expression was examined using immunoblotting analysis in the presence of HGF in MDA-MB-231 cells.The effects of NK4 transfection on growth and invasion were detected by MTT assay and Transwell assay.Results The pLenti6.3-NK4-IRES-EGFP transfected MDA-MB-231 cells expressed NK4,and the cells expressed less p-met in the presence of HGF.MTT results showed that the cell number decreased significantly after co-effected by pLenti6.3-NK4-IRES-EGFP and HGF(P〈0.01).By Transwell assay,pLenti6.3-NK4-IRES-EGFP plus HGF inhibited significantly cell invasion(P〈0.01).Conclusion In pLenti6.3-NK4-IRES-EGFP trasfected MDA-MB-231 cells,NK4 competitively inhibits the induction of HGF on phosphorylation of c-met.
出处 《山西医科大学学报》 CAS 2013年第3期192-195,248,共5页 Journal of Shanxi Medical University
关键词 NK4 乳腺癌 慢病毒载体 NK4 breast cancer lentivirus vector
  • 相关文献

参考文献4

二级参考文献25

  • 1Rubin JS, Chan AM, Bottaro DP, et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor[ J ]. Proc Natl Acad Sci USA, 1991,88 ( 2 ) :415- 419.
  • 2Yamashita J,Ogawa M, Yamashita S ,et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer [ J ]. Cancer Res, 1994,54 (7) : 1630-1633.
  • 3Eichbaum MH,de Rossi TM,Kaul S,et al. Serum levels of hepatocyte growth factor scatter factor in patients with liver metastases from breast cancer[J]. Tumour Biol,2007,28(1) :36-44.
  • 4Sheen-Chen SM, Liu YW, Eng HL, et al. Serum levels of hepatocyte growth factor in patients with breast cancer [ J ]. Cancer Epidemiolog'y Biomarkers & Prevention , 2005 ,14 ( 3 ) :715-717.
  • 5Pruefer FG, Unger-Saldana K, Mohamier L, et al. Tumor HGF lacks prognostic significance in mexican breast cancer patients [ J ]. J Exp Clin Cancer Res,2006,25 (3) :357-364.
  • 6Sakai K, Nakamora T, Matsumoto K, et al. Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association [J]. J Biol Chem,2009,284(33):22491-22499.
  • 7Matsumoto K, Nakamura T, Sakai K, et al. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4 [J]. Proteomics, 2008,8 ( 16 ) : 3360-3370.
  • 8Okasora T,Jo JI,Tabata Y. Augmented anti-tumor therapy through natural targetability of macrophags genetically engineered by NK4 plasmid DNA [ J J.Gene Ther, 2008,15 ( 7 ) : 524-530.
  • 9Wiedner K,Arakaki N,Vandekereckhove J,et al.Evidence for the identity of human scatter factor and human hepatocyte growth factor[J].Proc Natl Acad Sci USA,1991,88(16):7001.
  • 10Masashi M,Kohichi S,Takahiro Y,et al.Canine hepatocyte growth factor:molecular cloning and characterization of the recombinant protein.[J].Veterin Immu Immuno,2003,95 (3-4):135.

共引文献24

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部